SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-009813
Filing Date
2021-05-11
Accepted
2021-05-11 16:05:26
Documents
66
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q fhtx-20210331.htm   iXBRL 10-Q 859347
2 EX-31.1 fhtx-20210331xex311.htm EX-31.1 9826
3 EX-31.2 fhtx-20210331xex312.htm EX-31.2 9805
4 EX-32.1 fhtx-20210331xex321.htm EX-32.1 4395
5 EX-32.2 fhtx-20210331xex322.htm EX-32.2 4380
  Complete submission text file 0001628280-21-009813.txt   4672576

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fhtx-20210331.xsd EX-101.SCH 38181
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fhtx-20210331_cal.xml EX-101.CAL 79452
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fhtx-20210331_def.xml EX-101.DEF 150514
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fhtx-20210331_lab.xml EX-101.LAB 466851
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fhtx-20210331_pre.xml EX-101.PRE 281834
11 EXTRACTED XBRL INSTANCE DOCUMENT fhtx-20210331_htm.xml XML 701691
Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Filer) CIK: 0001822462 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39634 | Film No.: 21911244
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences